Arteriosclerosis, Thrombosis, and Vascular Biology. https://www.ahajournals.org/doi/full/10.1161/ATVBAHA.119.311996?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed.
---. https://www.ahajournals.org/doi/full/10.1161/ATVBAHA.110.207480.
Circulation Research. https://www.ahajournals.org/doi/full/10.1161/01.RES.0000252802.25497.b7.
---. https://www.ahajournals.org/doi/full/10.1161/CIRCRESAHA.116.309692.
---. https://www.ahajournals.org/doi/full/10.1161/CIRCRESAHA.116.308537.
---. https://www.ahajournals.org/doi/full/10.1161/CIRCRESAHA.117.312465.
De Backer, Daniel, and Todd Dorman. ‘Surviving Sepsis Guidelines’. JAMA, vol. 317, no. 8, Feb. 2017, https://doi.org/10.1001/jama.2017.0059.
Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour: Results From a Guideline-Based Performance Improvement Program* | Ovid. 2014, http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00003246&LSLINK=80&D=jbi.
Evans, Laura. ‘A Closer Look at Sepsis-Associated Mortality’. JAMA Network Open, vol. 2, no. 2, Feb. 2019, https://doi.org/10.1001/jamanetworkopen.2018.7565.
Frangogiannis, Nikolaos G. ‘Cardiac Fibrosis: Cell Biological Mechanisms, Molecular Pathways and Therapeutic Opportunities’. Molecular Aspects of Medicine, vol. 65, Feb. 2019, pp. 70–99, https://doi.org/10.1016/j.mam.2018.07.001.
Hafiane, Anouar, and Stella S. Daskalopoulou. ‘Extracellular Vesicles Characteristics and Emerging Roles in Atherosclerotic Cardiovascular Disease’. Metabolism, vol. 85, Aug. 2018, pp. 213–22, https://doi.org/10.1016/j.metabol.2018.04.008.
Howell, Michael D., and Andrew M. Davis. ‘Management of Sepsis and Septic Shock’. JAMA, vol. 317, no. 8, Feb. 2017, https://doi.org/10.1001/jama.2017.0131.
Huang, Shuaibo, and Nikolaos G. Frangogiannis. ‘Anti-Inflammatory Therapies in Myocardial Infarction: Failures, Hopes and Challenges’. British Journal of Pharmacology, vol. 175, no. 9, May 2018, pp. 1377–400, https://doi.org/10.1111/bph.14155.
Knaus, William A., and Richard D. Marks. ‘New Phenotypes for Sepsis’. JAMA, vol. 321, no. 20, May 2019, https://doi.org/10.1001/jama.2019.5794.
Komorowski, Matthieu, et al. ‘The Artificial Intelligence Clinician Learns Optimal Treatment Strategies for Sepsis in Intensive Care’. Nature Medicine, vol. 24, no. 11, Nov. 2018, pp. 1716–20, https://doi.org/10.1038/s41591-018-0213-5.
McPherson, Duncan, et al. ‘Sepsis-Associated Mortality in England: An Analysis of Multiple Cause of Death Data from 2001 to 2010’. BMJ Open, vol. 3, no. 8, Aug. 2013, https://doi.org/10.1136/bmjopen-2013-002586.
Norman, D. C. ‘Fever in the Elderly’. Clinical Infectious Diseases, vol. 31, no. 1, July 2000, pp. 148–51, https://doi.org/10.1086/313896.
Rhee, Chanu, et al. ‘Prevalence, Underlying Causes, and Preventability of Sepsis-Associated Mortality in US Acute Care Hospitals’. JAMA Network Open, vol. 2, no. 2, Feb. 2019, https://doi.org/10.1001/jamanetworkopen.2018.7571.
Seymour, Christopher W., et al. ‘Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis’. JAMA, vol. 321, no. 20, May 2019, https://doi.org/10.1001/jama.2019.5791.
Singer, Mervyn, et al. ‘The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)’. JAMA, vol. 315, no. 8, Feb. 2016, https://doi.org/10.1001/jama.2016.0287.
Sund-Levander, Martha, et al. ‘Normal Oral, Rectal, Tympanic and Axillary Body Temperature in Adult Men and Women: A Systematic Literature Review’. Scandinavian Journal of Caring Sciences, vol. 16, no. 2, June 2002, pp. 122–28, https://doi.org/10.1046/j.1471-6712.2002.00069.x.
Westman, Peter C., et al. ‘Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction’. Journal of the American College of Cardiology, vol. 67, no. 17, May 2016, pp. 2050–60, https://doi.org/10.1016/j.jacc.2016.01.073.
Wick, Georg, and Cecilia Grundtman, editors. Inflammation and Atherosclerosis. Springer Vienna, 2012, https://doi.org/10.1007/978-3-7091-0338-8.
Zhou, Shan-shan, et al. ‘miRNAS in Cardiovascular Diseases: Potential Biomarkers, Therapeutic Targets and Challenges’. Acta Pharmacologica Sinica, vol. 39, no. 7, July 2018, pp. 1073–84, https://doi.org/10.1038/aps.2018.30.